Arialys Therapeutics' precision medicine has shown preclinical potential to address the underlying cause of anti-NMDA ...

Diphenhydramine is the active ingredient in countless over-the-counter medications. But experts say there are serious risks to taking too much of the drug—or taking it too long.

Fos, are integral to the brain's response to stimuli. Initially identified as a proto-oncogene, c-Fos is essential for neural ...

Initially identified as a proto-oncogene, c-Fos is essential for neural activity, synaptic plasticity, and stress responses. While its transient expression supports memory formation in healthy brains, ...

Objectives This study explored knowledge of dementia, attitudes towards dementia risk prediction and barriers and facilitators to accessing dementia services for diverse populations in England. Design ...

NewAmsterdam Pharma’s push to show a cholesterol drug can prevent Alzheimer’s disease has passed another test. The phase 3 sub-study tracked significant changes in an Alzheimer’s biomarker ...

Night owls are more at risk for dementia — but not for the reasons you might think By . Tracy Swartz. Published June 4, 2025, 6:00 a.m. ET.

The annual Alzheimer's disease drug development pipeline report is led by Dr. Jeffrey Cummings, a renowned Alzheimer's clinician-scientist. The report reviews the status and associated trends ...

A new era in Alzheimer disease detection may be on the horizon with the development of a novel blood test. 1,2 This diagnostic tool, known as Penta-Plex Alzheimer’s Disease Capture Sandwich ...

A fully automated plasma biomarker panel detected amyloid-beta (Aβ) positivity and monitored early amyloid accumulation in middle-aged cognitively unimpaired (CU) adults at risk for Alzheimer's ...